By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Tapestry Pharmaceuticals, Inc. 

6304 Spine Road, Unit A

Boulder  Colorado  80301  U.S.A.
Phone: 303-516-8500 Fax: 303-530-1296


SEARCH JOBS


Industry
Pharmaceutical






Company News
Delisting of Securities of Tapestry Pharmaceuticals, Inc. (TPPH) From The NASDAQ Stock Market 5/1/2008 11:25:40 AM
Tapestry Pharmaceuticals, Inc. (TPPH) Receives Nasdaq Delisting Notice 4/9/2008 8:40:10 AM
Tapestry Pharmaceuticals, Inc. (TPPH) Receives Notice Regarding Minimum Bid Price Rule 12/26/2007 8:07:43 AM
Eric Rowinsky, M.D. and Martin Cannon Join Tapestry Pharmaceuticals, Inc. (TPPH) Board of Directors 12/5/2007 11:06:00 AM
Tapestry Pharmaceuticals, Inc. (TPPH) Reports Third Quarter 2007 Financial Results and Preliminary Data From Its Phase 2 Prostate Cancer Trial 11/5/2007 7:20:10 AM
Tapestry Pharmaceuticals, Inc. (TPPH) to Host Conference Call on November 5th to Discuss Third Quarter 2007 Financial Results 10/30/2007 8:27:03 AM
Tapestry Pharmaceuticals, Inc. (TPPH) to Host Conference Call on November 5th to Discuss Third Quarter 2007 Financial Results 10/29/2007 7:13:46 AM
Tapestry Pharmaceuticals, Inc. (TPPH) Announces Strategy to Focus on TPI 287 Clinical Program; Company Downsizing Non-clinical Workforce 10/26/2007 6:44:44 AM
Tapestry Pharmaceuticals, Inc. (TPPH) Presents Data on TPI 287 at the AACR-NCI-EORTC International Conference 10/24/2007 7:15:46 AM
Tapestry Pharmaceuticals, Inc. (TPPH) Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 10/3/2007 7:32:56 AM
123456789
//-->